These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28027314)

  • 1. Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma.
    Pandey M; Ozberk V; Calcutt A; Langshaw E; Powell J; Rivera-Hernandez T; Ho MF; Philips Z; Batzloff MR; Good MF
    PLoS Pathog; 2016 Dec; 12(12):e1006122. PubMed ID: 28027314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma.
    Karmarkar MG; Hule GP; Cameron A; Mehta PR; Khopkar U; Hase NK; Sriprakash KS
    BMC Infect Dis; 2015 Mar; 15():113. PubMed ID: 25849124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific opsonic antibodies in streptococcal pyoderma.
    Bisno AL; Nelson KE
    Infect Immun; 1974 Dec; 10(6):1356-61. PubMed ID: 4435959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia.
    Pandey M; Langshaw E; Hartas J; Lam A; Batzloff MR; Good MF
    J Immunol; 2015 Jun; 194(12):5915-25. PubMed ID: 25980008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of streptococcal pyoderma in an orphanage community of a tropical country.
    Brahmadathan KN; Koshi G
    J Trop Med Hyg; 1988 Dec; 91(6):306-14. PubMed ID: 3060623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help.
    Pandey M; Wykes MN; Hartas J; Good MF; Batzloff MR
    J Immunol; 2013 Mar; 190(6):2692-701. PubMed ID: 23401589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma in Israel due to Streptococcus pyogenes M type 'Potter C'.
    Seal DV; Wilkins E; Colman G
    Trans R Soc Trop Med Hyg; 1991; 85(2):306-7. PubMed ID: 1887498
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing serum antibody responses in streptococcal pyoderma.
    Bisno AL; Nelson KE; Waytz P; Brunt J
    J Lab Clin Med; 1973 Mar; 81(3):410-20. PubMed ID: 4686957
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
    Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
    J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma, group A streptococci and parasitic skin diseases -- a dangerous relationship.
    Feldmeier H; Singh Chhatwal G; Guerra H
    Trop Med Int Health; 2005 Aug; 10(8):713-6. PubMed ID: 16045456
    [No Abstract]   [Full Text] [Related]  

  • 11. A new M-type of group A streptococcus of clinical importance in pyoderma and pharyngitis.
    Dillon HC; Derrick CW; Gooch PE
    J Gen Microbiol; 1975 Nov; 91(1):119-26. PubMed ID: 1104766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic pyoderma caused by nephritogenic streptococci in college athletes.
    Glezen WP; Lindsay RL; DeWalt JL; Dillon HC
    Lancet; 1972 Feb; 1(7745):301-3. PubMed ID: 4109941
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of beta-haemolytic streptococci isolated from cases of pyoderma.
    Prabhakar H; Sarin RC; Kambo RM
    Indian J Pathol Microbiol; 1981 Jul; 24(3):171-5. PubMed ID: 7033129
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiological consequences of enduring strain-specific immunity requiring repeated episodes of infection.
    Chisholm RH; Sonenberg N; Lacey JA; McDonald MI; Pandey M; Davies MR; Tong SYC; McVernon J; Geard N
    PLoS Comput Biol; 2020 Jun; 16(6):e1007182. PubMed ID: 32502148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-serotypes of group A streptococci from skin lesions from a rural area of Delhi.
    Aggarwal P; Ichhpujani RL; Anand BR; Chowdhuri AN
    Indian J Med Res; 1983 Feb; 77():178-81. PubMed ID: 6345351
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriology & serology of streptococcal pyoderma.
    Raghunath D; Ramakrishnan KR; Chopra TR
    Indian J Med Res; 1985 Dec; 82():495-7. PubMed ID: 3914456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Formation of a skin ecotype of Streptococcus pyogenes during an epidemic].
    Krasil'nikov IA
    Vestn Akad Med Nauk SSSR; 1983; (5):47-52. PubMed ID: 6346733
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection.
    McDonald MI; Towers RJ; Fagan P; Carapetis JR; Currie BJ
    Epidemiol Infect; 2007 Nov; 135(8):1398-405. PubMed ID: 17306049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.